How do doctors treat lung cancer with KRAS mutations?

Medical oncologist and lung cancer expert Dr. Naomi Fujioka provides an overview of how lung cancers with KRAS mutations are treated. She discusses the use of KRAS inhibitors sotorasib and adagrasib that target the KRAS G12C mutation. She also discusses ongoing clinical trials researching how to combine KRAS inhibitors with other treatments, using KRAS inhibitors earlier in lung cancer treatment, and research on therapies targeting KRAS G12D.